Analysis of the cytokine profile in the duodenal mucosa of refractory coeliac disease patients

Clinical Science

Volumn 126, Issue 6, 2014, Pages 451-458

  Caruso, Roberta ^a   Marafini, Irene ^a   Sedda, Silvia ^a   Del Vecchio Blanco, Giovanna ^a   Giuffrida, Paolo ^b   Macdonald, Thomas T ^c   Corazza, Gino Roberto ^b   Pallone, Francesco ^a   Di Sabatino, Antonio ^b   Monteleone, Giovanni ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Anti tumour necrosis factor antibody; Gluten; Infliximab; Interleukin 15 (IL 15); Th1 cytokine; Th17 cytokine

Indexed keywords

CYCLOSPORIN; CYTOKINE; GLUTEN; INFLIXIMAB; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 6; PREDNISONE; RNA; STEROID; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL PAIN; ARTICLE; ASTHENIA; BLOATING; CELIAC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DUODENOSCOPY; DUODENUM BIOPSY; DUODENUM DISEASE; DUODENUM MUCOSA; ECHOGRAPHY; FEMALE; GLUTEN FREE DIET; HASHIMOTO DISEASE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE VILLUS ATROPHY; LABORATORY TEST; NUTRITIONAL INTOLERANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REFRACTORY CELIAC DISEASE; TH1 CELL; UPREGULATION;

ANTIBODIES, MONOCLONAL; CASE-CONTROL STUDIES; CELIAC DISEASE; CYTOKINES; DUODENUM; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, MUCOSAL; INTERLEUKIN-17; INTERLEUKIN-6; INTESTINAL MUCOSA; MIDDLE AGED; PROSPECTIVE STUDIES; RNA, MESSENGER; TH1 CELLS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84891420113     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20130478     Document Type: Article

References (40)

1. Sollid, L. M. (2000) Molecular basis of celiac disease. Annu. Rev. Immunol. 18, 53-81
2. Sollid, L. M. (2002) Coeliac disease: dissecting a complex inflammatory disorder. Nat. Rev. Immunol. 2, 647-655
3. Schuppan, D. (2000) Current concepts of celiac disease pathogenesis. Gastroenterology 119, 234-242
4. Bodd, M., Raki, M., Tollefsen, S., Fallang, L. E., Bergseng, E., Lundin, K. E. and Sollid, L. M. (2010) HLA-DQ2-restricted gluten-reactive T cells produce IL-21 but not IL-17 or IL-22. Mucosal Immunol. 3, 594-601
5. Nilsen, E. M., Lundin, K. E., Krajci, P., Scott, H., Sollid, L. M. and Brandtzaeg, P. (1995) Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon γ. Gut 37, 766-776
6. Fina, D., Sarra, M., Caruso, R., Del Vecchio Blanco, G., Pallone, F., MacDonald, T. T. and Monteleone, G. (2008) Interleukin 21 contributes to the mucosal T helper cell type 1 response in coeliac disease. Gut 57, 887-892
7. Monteleone, G., Pender, S. L., Alstead, E., Hauer, A. C., Lionetti, P., McKenzie, C. and MacDonald, T. T. (2001) Role of interferon α in promoting T helper cell type 1 responses in the small intestine in coeliac disease. Gut 48, 425-429
8. Maiuri, L., Ciacci, C., Auricchio, S., Brown, V., Quaratino, S. and Londei, M. (2000) Interleukin 15 mediates epithelial changes in celiac disease. Gastroenterology 119, 996-1006
9. Mention, J. J., Ben Ahmed, M., Begue, B., Barbe, U., Verkarre, V., Asnafi, V., Colombel, J. F., Cugnenc, P. H., Ruemmele, F. M., McIntyre, E. et al. (2003) Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology 125, 730-745
10. Monteleone, G., Pender, S. L., Wathen, N. C. and MacDonald, T. T. (2001) Interferon-α drives T cell-mediated immunopathology in the intestine. Eur. J. Immunol. 31, 2247-2255
11. Green, P. H. and Cellier, C. (2007) Celiac disease. N. Engl. J. Med. 357, 1731-1743
12. Di Sabatino, A. and Corazza, G. R. (2009) Coeliac disease. Lancet 373, 1480-1493
13. Al-Toma, A., Verbeek, W. H. and Mulder, C. J. (2007) Update on the management of refractory coeliac disease. J. Gastrointestin. Liver Dis. 16, 57-63
14. Ludvigsson, J. F., Leffler, D. A., Bai, J. C., Biagi, F., Fasano, A., Green, P. H., Hadjivassiliou, M., Kaukinen, K., Kelly, C. P., Leonard, J. N. et al. (2013) The Oslo definitions for coeliac disease and related terms. Gut 62, 43-52
15. Leffler, D. A., Dennis, M., Hyett, B., Kelly, E., Schuppan, D. and Kelly, C. P. (2007) Etiologies and predictors of diagnosis in nonresponsive celiac disease. Clin. Gastroenterol. Hepatol. 5, 445-450
16. Abdulkarim, A. S., Burgart, L. J., See, J. and Murray, J. A. (2002) Etiology of nonresponsive celiac disease: results of a systematic approach. Am. J. Gastroenterol. 97, 2016-2021
17. Nijeboer, P., van Wanrooij, R. L., Tack, G. J., Mulder, C. J. and Bouma, G. (2013) Update on the diagnosis and management of refractory coeliac disease. Gastroenterol. Res. Pract. 2013, 518483
18. Daum, S., Cellier, C. and Mulder, C. J. (2005) Refractory coeliac disease. Best Pract. Res. Clin. Gastroenterol. 19, 413-424
19. Cellier, C., Delabesse, E., Helmer, C., Patey, N., Matuchansky, C., Jabri, B., Macintyre, E., Cerf-Bensussan, N. and Brousse, N. (2000) Refractory sprue, coeliac disease, and enteropathyassociated T-cell lymphoma. Lancet 356, 203-208
20. Cellier, C., Patey, N., Mauvieux, L., Jabri, B., Delabesse, E., Cervoni, J. P., Burtin, M. L., Guy-Grand, D., Bouhnik, Y., Modigliani, R. et al. (1998) Abnormal intestinal intraepithelial lymphocytes in refractory sprue. Gastroenterology 114, 471-481
21. Malamut, G., Afchain, P., Verkarre, V., Lecomte, T., Amiot, A., Damotte, D., Bouhnik, Y., Colombel, J. F., Delchier, J. C., Allez, M. et al. (2009) Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II. Gastroenterology 136, 81-90
22. Rubio-Tapia, A., Kelly, D. G., Lahr, B. D., Dogan, A., Wu, T. T. and Murray, J. A. (2009) Clinical staging and survival in refractory celiac disease: a single center experience. Gastroenterology 136, 99-107
23. Meresse, B., Chen, Z., Ciszewski, C., Tretiakova, M., Bhagat, G., Krausz, T. N., Raulet, D. H., Lanier, L. L., Groh, V., Spies, T. et al. (2004) Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 21, 357-366
24. Meresse, B., Curran, S. A., Ciszewski, C., Orbelyan, G., Setty, M., Bhagat, G., Lee, L., Tretiakova, M., Semrad, C., Kistner, E. et al. (2006) Reprogramming of CTLs into natural killer-like cells in celiac disease. J. Exp. Med. 203, 1343-1355
25. Gross, S., van Wanrooij, R. L., Nijeboer, P., Gelderman, K. A., Cillessen, S. A., Meijer, G. A., Mulder, C. J., Bouma, G., von Blomberg, B. M. and Bontkes, H. J. (2013) Differential IL-13 production by small intestinal leukocytes in active coeliac disease versus refractory coeliac disease. Mediators Inflamm. 2013, 939047
26. Rubio-Tapia, A., Hill, I. D., Kelly, C. P., Calderwood, A. H. and Murray, J. A. (2013) ACG clinical guidelines: diagnosis and management of celiac disease. Am. J. Gastroenterol. 108, 656-676
27. Marsh, M. N. (1992) Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology 102, 330-354
28. Tagaya, Y., Bamford, R. N., DeFilippis, A. P. and Waldmann, T. A. (1996) IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity 4, 329-336
29. Van Deventer, S. J. (1997) Tumour necrosis factor and Crohn's disease. Gut 40, 443-448
30. Ferrara, J. L. (1998) The cytokine modulation of acute graft-versus-host disease. Bone Marrow Transplant. 21 (Suppl. 3), S13-S15
31. Stuber, E., Buschenfeld, A., von Freier, A., Arendt, T. and Folsch, U. R. (1999) Intestinal crypt cell apoptosis in murine acute graft versus host disease is mediated by tumour necrosis factor α and not by the FasL-Fas interaction: effect of pentoxifylline on the development of mucosal atrophy. Gut 45, 229-235
32. Al-Toma, A., Verbeek, W. H., Hadithi, M., von Blomberg, B. M. and Mulder, C. J. (2007) Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience. Gut 56, 1373-1378
33. Monteleone, I., Sarra, M., Del Vecchio Blanco, G., Paoluzi, O. A., Franze, E., Fina, D., Fabrizi, A., MacDonald, T. T., Pallone, F. and Monteleone, G. (2010) Characterization of IL-17A-producing cells in celiac disease mucosa. J. Immunol. 184, 2211-2218
34. Fujino, S., Andoh, A., Bamba, S., Ogawa, A., Hata, K., Araki, Y., Bamba, T. and Fujiyama, Y. (2003) Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52, 65-70
35. Kolls, J. K. and Linden, A. (2004) Interleukin-17 family members and inflammation. Immunity 21, 467-476
36. Iwakura, Y., Nakae, S., Saijo, S. and Ishigame, H. (2008) The roles of IL-17A in inflammatory immune responses and host defense against pathogens. Immunol. Rev. 226, 57-79
37. Weaver, C. T., Hatton, R. D., Mangan, P. R. and Harrington, L. E. (2007) IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 25, 821-852
38. Schmidt, C., Kasim, E., Schlake, W., Gerken, G., Giese, T. and Stallmach, A. (2009) TNF-α antibody treatment in refractory collagenous sprue: report of a case and review of the literature. Z. Gastroenterol. 47, 575-578
39. Gillett, H. R., Arnott, I. D., McIntyre, M., Campbell, S., Dahele, A., Priest, M., Jackson, R. and Ghosh, S. (2002) Successful infliximab treatment for steroid-refractory celiac disease: a case report. Gastroenterology 122, 800-805
40. Costantino, G., della Torre, A., Lo Presti, M. A., Caruso, R., Mazzon, E. and Fries, W. (2008) Treatment of life-threatening type I refractory coeliac disease with long-term infliximab. Dig. Liver Dis. 40, 74-77